Sickle Cell Disease Clinical Trials in Little Rock, Arkansas

3 studies are recruiting for sickle cell disease in Little Rock, Arkansas right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease

    This study is conducted to confirm whether etavopivat works well at reducing the number of Vaso-occlusive crisis VOCs (sickle cell pain crises) caused by obstructions in blood vessels in adults and adolescents living with sickle cell disease. The study will also evaluate how well etavopivat can red…

    Stage
    Phase 3
    Ages
    12 and older
    Site
    Arkansas Children's Hospital, Little Rock, Arkansas
    Locations
    175 in total
    Run by
    Novo Nordisk A/S

    See if you can join NCT06612268 on ClinicalTrials.gov

  2. ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

    In parallel with the growth of ATHN's clinical studies, the number of new therapies for all blood disorders is increasing significantly. Some of the recently FDA-approved therapies for congenital and acquired hematologic conditions have not yet demonstrated long-term safety and effectiveness beyond…

    Stage
    Not phased
    Ages
    Any age
    Site
    Arkansas Center for Bleeding Disorders, Little Rock, Arkansas
    Locations
    76 in total
    Run by
    American Thrombosis and Hemostasis Network

    See if you can join NCT04398628 on ClinicalTrials.gov

  3. Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)

    This is a phase 2a, global, multicenter, randomized, double-blind, placebo-controlled study investigating the safety of anumigilimab administered subcutaneously (SC) at the maximum tolerated dose (MTD) in adult participants with SCD. The primary aim of the study is to assess the safety of anumigili…

    Stage
    Phase 2
    Ages
    18 and older
    Site
    UAMS Medical Center, Little Rock, Arkansas
    Locations
    16 in total
    Run by
    CSL Behring

    See if you can join NCT07224360 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.